CIN NO; L748990L1985PL6022468

BRAWN

To, Date: 22-05-2019The Secretary,Listing Department,BSE Limited,Floor 25, Phirozee Jeejeebhoy Towers,Dalal Street,Mumbai- 400001

Sub: Outcome of 2"‘1 / 2019- 20 Board Meeting and Submission of Audited FinancialResults & Statement of Assets & Liabilities for the quarter and year ended 31.03.2019

SCRIP CODE: 530207

Dear Sir,

Pursuant to provisions of Regulation 30 and 33 and any other applicable provisions, if any, ofthe Securities and Exchange Board ofIndia (Listing Obligations and Disclosure Requirements)Regulations, 2015,(hereinafier “SEBI Listing Regulations”, this is to inform that the Board ofDirectors of the Company in its meeting held today, i.e. 22"d day of May, 2019 have inter—alia considered, approved and taken on record the followingsz—

‘

The audited standalone financial results along with Statement of Assets & Liabilities of the

Company for the fourth quarter(Q4) and financial year ended 31“ March, 2019, which was

recommended by the Audit Committee at their meeting held on May 22“, 2019, copies whereof

alongwith audit report for standalone results and declaration by the ChiefFinancial Officer ofthe Company in terms of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015 are enclosed herewith.

The meeting of the Board ofDirectors was commenced at 03.00 RM. and concluded at 05.00 P.M.

You are requested to take above on record.

Thanking you,

For BRAWN BIOTECH LIMITED

,r-JEIV‘JDELHI’

‘1’ "02 EPriyanka Shanna

,

0/Company Secretary-

,.

Encl.: As above

BRAWN BIOTECH LTD.

{44 Me(Formerly Known as Brawn Pharmaceuticals Ltd,)' ' ' W

Regd. Office : 4B, AsafAti Road, || Floor, Delhi Stock Exchange Building, New Delhi 110002 IN Tel' 0124—4666152, 4222462,

Email: solution@brawnbiotechconj. Website : wwwvbrawnbiotechcom

Export Office : 4B, AsafAIl Road. || Floor, Delhi Stock Exchange Budding. New Delhi 110002 IN Tel: 011-23275208 Fax‘

011-23275208

Corporate Office : Plot No, — 30, Sector - 33,

Near Hero Honda Factory, Gurugrarn (Haryana) 122001,

Tel.: 01244666152, 4222462

Emaii' solution@brawnbiotech.com

Works: 13. Industrial Area, N.|,T. Faridabad 421001 (Haryana) Tel,: +91 7 8010416849/48

CIN NO.: L7489SDL1985PL6022468

BRAWN BIOTECH LIMITED

UN:I.74899DL1935H.C022468REGD. OFFICE: ‘3, MIA" Road. II Flmr, Delhl Slock Man Bulldln New Delhl 110002

STAYIMIN'I 0' STANDALDNI AUIIII’ED "MANUAL [BULB '0! THE QIlAlTII‘I lVIA! INDID 3131 MAIL" 1019I:- III he!5r.

PamcullrsQuaner Ended

Var [mindNo.

31-Mar-19 | 31-Dec-10 ] 31-Mar-10 31-Mar-19 1 31-Mar-15Audlled I Uri-audited | Audnea .40de l Audrred1 Revenue from operauons

Revenue tram npenllnns1,542.45 2,123.35 1,570.51 5,517.90 5 575.37mm Income

55.20 0.15 25.52 73.75 5.97TnIaI nevenue

1,505.73 2 129.52 1,595.03 5,591.55 5 551.342 Burma:

a Costufmaterlal consumed-

--

-

-0 Purchase nistock—ln-lrade

1,395.03 1,933.27 1,390.75 5,545.92 4,552.19C Change In Invemorles oIflnlshed 30011:, work In progress and stock In trade

(0.00) 2.34 5.24 0.90 2.45a Empluyee 5enenr expenses

51.45 104.73 03.43 302.49 295.192 Depretlarlon 2nd amunrsarion expenses

0.79 0.51 0.75 3.20 3.15f Finance Cast

2.15 2.15 1.53 5.11 5.735 other expenses91.09 43.75 79.75 249.50 199.50Total nx—enses

1,559.72 2,057.00 1,554.51 5,411.15 5 391.243 From from apenuon berore Other Income. excepunnal and enra-ordInaryItems (1-2)

35.00 35.44 31.42 150.54 195.104 Other Income

--

-

--

5 Prnlll 1mm nrdlnaly acuvrtles nurnre exeepuonaI Ire-n: (3-4) 35.00 35.44 31.42 150.54 195.105 Exce llunal Irernr

.-

.

..

7 Pmfll fl'uln ordlnary acuvmes herore lax (5-5)35.00 95.44 31.42 150.54 195.10

5 1;, l?‘

5.52 10.23 15.32 47.24 57.949 Prom (Loss) (or zhe perlod from mnllnulng operations (7-5) 30.49 25.21 15.10 139.29 125.1510 Pram/(loss) fmm disconunuIng operations

--

-

--11 Tax expense ofdlscontlnulng npendnns

--

-

--

12 Profit/(lass) from mmnunulng operannns (aner tax) (10-11] ..

-

.

.13 Profit (L055) {or rho perIud (9.12)

30.49 25.21 15.10 139.29 120.1514 other Camprehenslve Income

0.07 0.33 0.91 5.53 (274)Tom ComprensIve Income30.55 25.54 17.01 135.52 125.42

15 means orequny share eapIraI100.03 300.03 300.09 300.03 300.03Paid-up equlry share capital

Face vque olequlty share czplul15 Reserve excluding Revalnzllon nererve17 Eamlngs perxhare

I 35le Earnings per share1.02 0.55 0.57 4.53 4.15II nIIured earnings pershure1.02 0.55 0.57 4.53 4.15501115 :-

2 The Slatumlv Audllors carried out the audlt lor year ended 315! March, 2019. "In management has :xelclsed necessary due dllllenc' In lnsllfl (hi! "I! financial rlsulls pluvldlda true and fair vlew OI Its anal“.

3 Thu above results hiva been prepared in cnmnllance with fill "cognition and measurement Drlnclplls n' th' Companies (Indlan Aflwunllnl Standards) nulls, 2015 (Ind AS), 15amended hv tha Comnanles (Indlan Accounxlnl Standards) [Amandmanl nil-s), 1015 pmscrlbad undo! Secflon 133 nl Ill! companies Act, 2013 and other "mulled Iocaunllulpracllces and policies In Ihe 0mm ippllmbll.The Cnmnany I5 engaged primarily III the business 01 Phlrmamlfllfils. Accaldln‘lv, (here Is m7 sepame vaportahla segments is Del Ind-AS 105 delllnfl with Overall": Saflmanls.

e.

u- The above Standalnne ,“i- audited Financial Rasul's '01 "I0 quark! and year nndad ended on 31.03-2019 are available on company's wehslte www.hlawnblatech.cam and BSEwebsllu wwwbxelndiamum.

Prlvlaus year/ period figures have been rexruuped / wirnnund, Wham/5! namxsary (a make them campavahle with Illa current parlod flluvu.

m

Place: B llrl

BRAWN BIOTECH LTD.l W W(Formerly Known as Brawn Pharmaceuticals Ltd.)

4B AsalAli Road. ll Floor, Delhi Stock Exchange Building. New Delhi 110002 IN Tel. 0124-4666152, 4222462,Regal. Office :

.

Email: solution@brawnblotechcom. Website:www.brawnbiotech.cum

>

1 23275208Export office : AB AsalAIi Road, || Floor, Delhi Stock Exchange Building. New Delhi 110002 IN Tel: 011—23275208 Fax .

0121-162Corporate Office : Flo! No. v 30. Sector , 33 . Near Hero Honda Factory, Gurugram (Haryana) 122001 16401244666152.4122

Email: solution@brawnbrotech.com

Works: 13. lnduslrial Area. N.|.T.. Farldanad -121001 (Haryana) Tel: +91 — 8010415849/48

CIN No.1 L14899DL1985PL0022463

BRAWN IMWN BIOTECH lIMITED

CIN:L7489‘)DLI9BSPLCDZZQEB

and office: 4B. Asaf All Road, II Floor, Delhi Stuck Exchange Building, New Delhi 110001

Rs. In LacsStatement of Assets and Llublllttes as an 315: March 2019

Particulars 31<Mar-19 31 ~Mar-18Audlled Audlled

ASSETS

(1) Non-current Aunts

Property, Plant and Equipment 19.17 2225Financial Assets

-

-lnvestment-

- Trade Receivable46.69 47.66

-Loan4.60 3.14

Deferred Tax Asset (Net) 6.28 8.00

76.75 81.08(2) Current Anon

Inventories33.85 34.76

Financial Assets-

- Trade Receivables1,645.77 1,505.42

- cash and cash equivalents54.47 39.61

- Loan-

-

- omer Financial Assets12.65 12.65

Current Tax Assets (Net) 154.86 109.86Other Current Assets

273.33 473.85

2,174.95 2,176.15TOTAL ASSETS

2,251.89 2,257.23

EQUITY AND LIABILITIES

EQUITV

Equity Share Capital 300.03 300.03Other Equity 565.68 463.07

865.71 763.10LIABILITIES

(1) Non-current Liabilities

Financial Liabilities- Trade Payable 1.22 3.32— Other Financial Liabilities

-

Provisions14.51 16.72

Deferred Tax liabilities (Net) -

-

15.72 20.05(2) Current Liabilities

Financial Liabilities- Trade Payables

1,034.51 1,122.55» Other Financial Liabilities

86.46 112.78Other current liabilities

77.72 83.16Provisions

14.39 43.95Current tax liabilities

156.87 111.34

1,370.25 1,474.09TOTAL EQUITY AND LIABILITIES

2,251.69 2,257.23

Far and on behalf of B .

For Brawn Biotech '

1 Q7(

2N ew DELHI E

110002

Date : 22 5-2019

BRAWN BIOTECH LTD.

”for; W age(Formerly Known as Brawn Pharmaceuticals Ltd.)

43, AsafAli Road. || Floor, Delhi Stock Exchange Building, New Delhi 110002 IN Tel: 01244666152, 4222462.

Email: solution@brawnbiotech com, Website : www.brawnbiotech.com

4B, AsafAli Read, ll Floor, Delhi Stock Exchange Building, New Delhi 110002 IN Tel: 011-23275208 Fax : 011-23275208

Plot No, - 30. Sector - 33,Near Hero Honda Factory, Gurugram (Haryana) 122001 ,Tel.: 0124—4666152, 4222462

Email: soluti0n@brawnbiotech.oom

Works: 13. IndustrialArea, N.I.T., Faridabad 7121001 (Haryana) Tel : +91 » 8010416849/48

Regd. Office :

Export Office :

Corporate Office :

RAIIV UDAI 81 ASSOCIATES

CHARTERED ACCOUNTANTS

Auditor's Report on Quarterly Financial Results and Year to Date Results of the Company

Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements)

Regulations, 2015

To

The Board of Directors of

Brawn Biotech Limited

We have audited the quarterly financial results of Brawn Biotech Limited (the "Company") for the quarter ended 31“

March. 2019 and the year to date results for the period 01" April 2018 to 315‘ March 2019 attached herewith, being submitted

by the company pursuant to the requirement of Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements)

Regulations. 2015. These quarterly financial results as well as the year to date financial results have been prepared on the

basis of the interim financial statements, which are the responsibility of the company's management. Attention is drawn to the

fact that figures for the quarter ended 31 March 2019 and the corresponding quarter ended in the previous year as reported

in these annual financial results are the balancing figures between audited figures in respect of the full financial year and the

published year to date figures up to the end of the third quarter of the relevant financial year. Also the figures up to the end of

the third quarter had only been reviewed and not subjected to audit.

Our responsibility is to express an opinion on these financial results based on our audit of such Interim financial statements,

which have been prepared in accordance with the recognition and Measurement principles laid down in Ind Accounting

Standard for Interim Financial Reporting ( Ind AS 34 ). prescribed, under Section 133 of the Companies Act, 2013 read with

relevant rules issued there under; or by the Institute of Chartered Accountants of India, as applicable and other accounting

principles generally accepted in India.

We conducted our audit in accordance with the auditing standard generally accepted in India. Those standards require that

we plan and perform the audit to obtain reasonable assurance about whether the financial results are free of material

misstatement(s). An audit includes examining, on a test basis, evidence supporting the amounts disclosed in financial results.

An audit also includes assessing the accounting principles used and significant estimates made by the Management. We

believe that our audit provides a reasonable basis for our opinion.

The comparative financial information of the company for the corresponding quarter and year ended March 31, 2018 included

in these financial results. are based on the previously issued financial results prepared in accordance with the recognition and

measurement principles specified under section 133 of the Companies Act, 2013, read with relevant rules issued there under

and other accounting principles generally accepted in India.

In our opinion and to the best of our information and according to the explanations given to us. the accompanying statement:

(i) is presented in accordance with the requirement of Regulation 33 of the SEBI (Listing obligations and Disclosure

Requirements) Regulations, 2015 in this regard; and

(ii) Give a true and fair view of the net profit and other financial information for the quarter and year ended 31“ March 2019.

For Rajiv Udai & Associates

Chartered Accountants

Fir egistration No. 18764N

C)’ ‘4.” '30.?“f‘” 'x

1

RajeevJai fl)gar“

r?(Partner) I" 3

Membership No. 99767 it}: .

Place: Delhi

Date: 22.05.2019

Head Office : A—36, 1st Floor, Guru Nanak Pura, Near Metro Pillar No. 57, Vikas Marg. Laxmi Nagar, Delhi-110092

Phone : 011-49027875, Mobile : 9312253876, E-mail : info@rajivudai.com, rajiv@rajivudai.comWeb. : www.rajivudai.com

CIN NOi: L748990L1985FL6022468

1“BRAWN

‘

To, Date: 22.05.2019

The Secretary

Listing DepartmentBSE Limited

Floor 25, Phirozee Jeejeebhoy Towers,Dalal Street, Mumbai- 400001

Sub: Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure

Requirements) Regulations, 2015

Scrip Code: 530207

In compliance with the provisions ofRegulation 33(3)(d) of the SEBI (Listing Obligations and

Disclosure Requirements) Regulations, 2015, we hereby declare that M/s Rajiv Udai &

Associates, Chartered Accountant, Statutory Auditor of the Company have issued an Audit

Report with unmodified opinion on Audited Standalone Financial Results of the Company for

the Quarter and Financial year ended 3lst March, 2019.

Kindly take note of the same.

Thanking you

Yours Faithfully

For Brawn Biote';..

.:

e?

(Formerly Known as Brawn Pharmaceuticals Ltd.)' ' 6 6

Regd. Office : 4B. AsafAli Road. || Floor. Delhi Stock Exchange Building. New Delhi 110002 N Tel‘ 0124-4666152. 4222462.

Email‘ solution@brawnbiotech.com. Website : www.brawnbiotech com

Export Office : 4B. Asat Ali Road, It Floor. Delhi Stock Exchange Building. New Delhi 110002 IN Tel: 011-23275208 Fax : 011-23275208 I

Corporate Office : Plot No. A 30, Sector - 33.Near Hero Honda Factory. Gurugram (Haryana) 122001 ,Tei.: 0124-4666152. 4222462

Email: solution@brawnbioteoh.com

A L _,- V.L - Works: 13, Industrial Area. N.|.T.. Faridabad 421001 (Haryana) Tel : +91 - 8010416849/48